Article ; Online: Nanofactories for Controlled Synthesis and Delivery of Nucleoside Analogue Therapeutics.
Chembiochem : a European journal of chemical biology
2020 Volume 21, Issue 22, Page(s) 3186–3188
Abstract: The ultimate nanomedicine will be a cell-like machinery capable of reaching a specific target in the body and performing a desired therapeutic action in a controlled fashion. To make such machinery a reality, we need to combine fundamental knowledge and ... ...
Abstract | The ultimate nanomedicine will be a cell-like machinery capable of reaching a specific target in the body and performing a desired therapeutic action in a controlled fashion. To make such machinery a reality, we need to combine fundamental knowledge and technological developments in different areas including polymer chemistry, biology, enzymology, and biochemical engineering. In this viewpoint, I put forward my vision of creating a nanofactory as a step towards developing cell-like nanomedicines. To make the proposed nanofactory a reality there are many challenges ahead. I propose plausible solutions to address some of the main challenges. |
---|---|
MeSH term(s) | Animals ; Drug Delivery Systems ; Humans ; Nanomedicine ; Nucleosides/chemical synthesis ; Nucleosides/chemistry |
Chemical Substances | Nucleosides |
Keywords | covid19 |
Language | English |
Publishing date | 2020-09-16 |
Publishing country | Germany |
Document type | Journal Article |
ZDB-ID | 2020469-3 |
ISSN | 1439-7633 ; 1439-4227 |
ISSN (online) | 1439-7633 |
ISSN | 1439-4227 |
DOI | 10.1002/cbic.202000382 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.